Glenmark receives approval from Russia to market Montlezir
[ad_1] It’s indicated for the therapy of seasonal and perennial allergic rhinitisin sufferers above 15 years of age Glenmark Prescribed drugs has introduced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocetirizine Dihydrochloride 5mg + Montelukast Sodium 10mg) film-coated tablets as a prescription product for the therapy of seasonal and perennial allergic … Read more